In Treatment of Depression Mvit Forte Capsule is a combination medicine that helps in maintaining the balance of certain chemicals in the brain that affect mood and behavior. This improves your mood, relieves anxiety, tension, helps you sleep better and increases your energy levels. Mvit Forte Capsule prevents extreme changes in mood and helps you feel less agitated. You may experience fewer episodes of depression and low mood. It can take several weeks for this medicine to work and you may still feel low during this time. It is likely that you will take this medicine for at least six months but possibly much longer. It needs to be taken regularly to work effectively. Do not stop taking it unless your doctor tells you to.
It is unsafe to consume alcohol with Mvit Forte Capsule.
Mvit Forte Capsule may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Information regarding the use of Mvit Forte Capsule during breastfeeding is not available. Please consult your doctor.
Mvit Forte Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
There is limited information available on the use of Mvit Forte Capsule in patients with kidney disease. Please consult your doctor.
Mvit Forte Capsule should be used with caution in patients with liver disease. Dose adjustment of Mvit Forte Capsule may be needed. Please consult your doctor.
If you miss a dose of Mvit Forte Capsule, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Arinna Lifescience Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Tas Med India Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Medivision Pharm || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Theo Pharma Pvt Ltd || ₹14.5/tablet (25% cheaper)